secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2024-07-17T23:59:59+00:00
Accession:  0001213900-24-062099
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital Acquisition Corp. dismisses Marcum LLP, appoints Marcum Asia as auditor
--------------------------------------------------------------------------------

- Dismissed Marcum LLP as independent auditor effective July 15, 2024, upon Audit Committee recommendation.
- Marcum's reports for FY 2023 and 2022 had a going concern explanatory paragraph but no adverse opinion or disagreements.
- Appointed Marcum Asia CPAs LLP as new independent auditor for the fiscal year ending December 31, 2024, effective July 15, 2024.
- No reportable events or disagreements occurred during the prior two fiscal years and subsequent interim periods.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024062099/0001213900-24-062099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390024062099/ea0209521-8k_denali.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-062099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer